CoChat

AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders

Open access
Preidis, Geoffrey A., Weizman, Adam V., Kashyap, Purna C., Morgan, Rebecca L. · 2020 · Gastroenterology
Cited by 127

The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.

Abstract

Probiotics are live microorganisms that, when consumed in adequate amounts, confer a health benefit on the host. 1 The probiotics industry is growing rapidly, with sales in the United States alone expected to exceed $6 billion in 2020. 2 However, probiotics are a source of significant cost with unclear benefit. Patients routinely ask clinicians whether they should be taking probiotics and, if so, which products. These questions present a dilemma, given that none of the probiotic preparations being studied are currently manufactured as drugs, that is, with the intent of treating, mitigating, or preventing disease. Rather, the typical classification of probiotics as dietary supplements has been associated with diminishment of the rigor of clinical studies, including capturing adverse events and efficacy end points. To date, general practitioners and gastroenterologists have minimal guidance regarding the use of probiotics for gastrointestinal disorders. In technical review, the reviews probiotic formulations that have been studied to prevent or treat common disorders of the gastrointestinal tract. This review provides evidence-based information to guide both clinicians and patients regarding whether probiotics might play a role in the management of these disorders. When sufficient evidence exists, this review also suggests which individual population. 272 We identified a recent systematic review and network meta-analysis comparing various probiotics for the prevention of mortality and morbidity in preterm infants. 273 This study identified 63 trials 274–336 examining 15,712 infants that compared single- and multiple-strain probiotics to placebo for the patient-important outcomes of severe NEC (stage II or higher based on Bell’s criteria), all-cause mortality, culture-proven sepsis, NEC-related mortality, duration of hospitalization, weight at 37 weeks gestational age or at discharge, time to establish full enteral feeds (days), and feeding intolerance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2020.05.060

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 71 references

Cited by

See all 127

Metadata

Authors
Preidis, G. A., Weizman, A. V., Kashyap, P. C., & Morgan, R. L.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2020-08
Volume
159
Issue
2
Pages
708-738.e4
ISSN
0016-5085 (ISSN-L)
OpenAlex
W3034349978
Cited by
127
References
71
FWCI
11.45
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders. https://app.cochat.ai/papers/10.1053/j.gastro.2020.05.060
The paper
Preidis, G. A., Weizman, A. V., Kashyap, P. C., & Morgan, R. L. (2020). AGA Technical Review on the Role of Probiotics in the Management of Gastrointestinal Disorders. Gastroenterology. https://doi.org/10.1053/j.gastro.2020.05.060

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.